Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models.

Saved in:
Bibliographic Details
Title: Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models.
Authors: Takahashi H; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan.; Pharmaceutical Research and Development Division, Yakult Honsha Co., Ltd, Tokyo, Japan., Miyoshi N; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan., Murakami H; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan., Okamura Y; Pharmaceutical Research and Development Division, Yakult Honsha Co., Ltd, Tokyo, Japan., Ogo N; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan., Takagi A; Yakult Central Institute, Yakult Honsha Co., Ltd, Tokyo, Japan., Muraoka D; Division of Translational Oncoimmunology, Aichi Cancer Research Institute, Naogya, Japan., Asai A; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan. aasai@u-shizuoka-ken.ac.jp.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Jul; Vol. 72 (7), pp. 2473-2482. Date of Electronic Publication: 2023 Apr 05.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37017695
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Takahashi+H%22">Takahashi H</searchLink>; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan.; Pharmaceutical Research and Development Division, Yakult Honsha Co., Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Miyoshi+N%22">Miyoshi N</searchLink>; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan.<br /><searchLink fieldCode="AU" term="%22Murakami+H%22">Murakami H</searchLink>; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan.<br /><searchLink fieldCode="AU" term="%22Okamura+Y%22">Okamura Y</searchLink>; Pharmaceutical Research and Development Division, Yakult Honsha Co., Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ogo+N%22">Ogo N</searchLink>; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan.<br /><searchLink fieldCode="AU" term="%22Takagi+A%22">Takagi A</searchLink>; Yakult Central Institute, Yakult Honsha Co., Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Muraoka+D%22">Muraoka D</searchLink>; Division of Translational Oncoimmunology, Aichi Cancer Research Institute, Naogya, Japan.<br /><searchLink fieldCode="AU" term="%22Asai+A%22">Asai A</searchLink>; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-Ku, Shizuoka-Shi, Shizuoka, 422-8526, Japan. aasai@u-shizuoka-ken.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2023 Jul; Vol. 72 (7), pp. 2473-2482. <i>Date of Electronic Publication: </i>2023 Apr 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37017695
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-023-03440-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2473
    Titles:
      – TitleFull: Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Takahashi H
      – PersonEntity:
          Name:
            NameFull: Miyoshi N
      – PersonEntity:
          Name:
            NameFull: Murakami H
      – PersonEntity:
          Name:
            NameFull: Okamura Y
      – PersonEntity:
          Name:
            NameFull: Ogo N
      – PersonEntity:
          Name:
            NameFull: Takagi A
      – PersonEntity:
          Name:
            NameFull: Muraoka D
      – PersonEntity:
          Name:
            NameFull: Asai A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 72
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1